NASDAQ:INMB
Inmune Stock News
$11.20
-0.370 (-3.20%)
At Close: May 06, 2024
IPHA LOSS NOTICE: Rosen Law Firm Announces Investigation of Securities Claims Against Innate Pharma S.A – IPHA
12:00am, Wednesday, 21'st Oct 2020
Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Innate Pharm
INmune Bio (INMB) Investor Presentation - Slideshow
10:08am, Thursday, 03'rd Sep 2020
The following slide deck was published by INmune Bio, Inc. in conjunction with this event..
The Daily Biotech Pulse: Gilead's Filgotinib Stumbles With FDA, J&J Laps Up Momenta In $6.5B Deal, 2 IPOs
12:00am, Wednesday, 19'th Aug 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 18)
Avenue Therapeutics Inc (NASDAQ: ATXI)
Checkmate Pharmaceuticals Inc (NASDAQ: CMPI)
DarioHealth Corp (NASDAQ:...
European Patent Granted Covering INmune Bio’s XPro1595
01:00pm, Thursday, 13'th Aug 2020
LA JOLLA, Calif., Aug. 13, 2020 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the, “Company”), a clinical-stage immunology company focused on developing treatments that harness the patient�
INmune Bio, Inc. Announces Second Quarter 2020 Results and Provides Business Update
08:01pm, Wednesday, 05'th Aug 2020
The company will host an earnings call: Today, August 5 at 4:30 PM ETLA JOLLA, Calif., Aug. 05, 2020 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), an immunology company d
INmune Bio, Inc to Present at the BTIG Virtual Biotechnology Conference 2020
11:00am, Monday, 03'rd Aug 2020
LA JOLLA, Calif, Aug. 03, 2020 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the “Company” or “INmune”), a clinical-stage immunology company focused on developing treatments that harn
INmune Bio, Inc. Schedules Conference Call to Report 2020 Second Quarter Financial Results
11:00am, Friday, 31'st Jul 2020
LA JOLLA, Calif, July 31, 2020 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the “Company” or “INmune”), a clinical-stage immunology company focused on developing treatments that harn
INmune Bio, Inc. Featured on Fox News (VIDEO): STNF and Cytokine Storm
11:00am, Monday, 27'th Jul 2020
LA JOLLA, Calif, July 27, 2020 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company focused on developing treatments that harness the patient�
Southern California Bancorp Announces Results for the Second Quarter 2020
12:00am, Monday, 27'th Jul 2020
Southern California Bancorp (the “Company”) (OTC Pink: BCAL), the holding company for Bank of Southern California, N.A. (the “Bank”) today reported re
LA JOLLA, Calif., July 20, 2020 -- In a release issued under the same headline on Monday, July 20th by INmune Bio, Inc. (NASDAQ: INMB) was incorrectly reported with below.
LA JOLLA, Calif., July 20, 2020 -- INmune Bio, Inc. (NASDAQ: INMB) (the “Company” or “INmune”), a clinical-stage immunology company focused on developing treatments that.
INmune Bio (NASDAQ:INMB) Trading Down 15.8%
05:40am, Saturday, 18'th Jul 2020
Shares of INmune Bio Inc (NASDAQ:INMB) dropped 15.8% during mid-day trading on Thursday . The stock traded as low as $13.03 and last traded at $10.99, approximately 104,136 shares changed hands during
INmune Bio, Inc. Prices Public Offering of Common Stock
01:15pm, Thursday, 16'th Jul 2020
LA JOLLA, Calif, July 16, 2020 -- INmune Bio, Inc. (NASDAQ: INMB) (the “Company” or “INmune”), a clinical-stage immunology company focused on developing treatments that.
INmune Bio: Stronger Support From Alzheimer's Drug XPro1595
08:23am, Thursday, 16'th Jul 2020
INmune Bio's Alzheimer's drug XPro1595 reduced neuroinflammation in AD patients. The results were ahead of October guidance; probably the reason investors bid the price up so high.
INmune Bio, Inc. Announces Proposed Public Offering of Common Stock
08:10pm, Wednesday, 15'th Jul 2020
LA JOLLA, Calif., July 15, 2020 -- INmune Bio, Inc. (NASDAQ: INMB) (the “Company” or “INmune Bio”), a clinical-stage immunology company focused on developing treatments that.
